NKTX peer analysis
Nkarta (NKTX) against its competitors: price, today's move, 1-year return and market value side by side.
NKTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALEC Alector | $2.55 | 11.35% | 96.15% | $379.64M |
| ELTX Elicio | $1.51 | 7.86% | -83.35% | $40.91M |
| FATE Fate Therapeutics | $1.99 | 8.45% | 91.35% | $241.92M |
| MOLN Molecular Partners | $3.21 | -0.98% | – | – |
| PEPG PepGen | $2.45 | -0.81% | -41.81% | $169.69M |
| VOR Vor Biopharma | $20.43 | 2.77% | 7.70% | $1.26B |
| NKTX Nkarta | $1.53 | -11.56% | -22.34% | $109.59M |
- NKTX's peers: ALEC (Alector), ELTX (Elicio), FATE (Fate Therapeutics), MOLN (Molecular Partners), PEPG (PepGen), VOR (Vor Biopharma).
Updated 2026-11-09 19:47 UTC